Breast risk cancer and environmental endocrine disruptors;Perturbateurs endocriniens environnementaux et cancer du sein : de nouveaux facteurs de risque ?

Gynecologie Obstetrique et Fertilite

Volumn 36, Issue 10, 2008, Pages 969-977

  Fenichel P ^a   Brucker Davis, F ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

Breast cancer; Environmental endocrine disrupters; Fetal exposition; Pesticide; Xenoestrogens

Indexed keywords

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHYLENE; 2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ANTIESTROGEN; ATRAZINE; BIOLOGICAL MARKER; BIPHENYL DERIVATIVE; CARCINOGEN; CHLORDECONE; COUMESTROL; DIELDRIN; DIETHYLSTILBESTROL; DIOXIN; ENDOCRINE DISRUPTOR; ESTRADIOL; ESTRIOL; ESTRONE; ETHINYLESTRADIOL; HEXACHLOROBENZENE; INDUSTRIAL CHEMICAL; LINDANE; METHOXYCHLOR; ORGANIC COMPOUND; ORGANOCHLORIDE PESTICIDE; PESTICIDE; PHYTOESTROGEN; POLYCYCLIC AROMATIC HYDROCARBON; TAMOXIFEN; UNCLASSIFIED DRUG; XENOBIOTIC AGENT; ZERANOL;

ADIPOSE TISSUE BLOOD FLOW; ARTICLE; BIOACCUMULATION; BREAST CANCER; CANCER RISK; ENVIRONMENTAL DISEASE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; ESTROGEN ACTIVITY; ESTROGEN SYNTHESIS; GENETIC SUSCEPTIBILITY; HUMAN; INCIDENCE; MOLECULAR DYNAMICS; TOXICOLOGY;

EID: 53549135746     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2008.05.006     Document Type: Article

References (73)

1. Fenton S.E. Endocrine-disrupting compounds and mammary gland development: early exposure and later life consequences. Endocrinology 147 6 Suppl (2006) S18-24
2. Davis D.L., Axelrod D., Bailey L., Gaynor M., and Sasco A.J. Rethinking breast cancer risk and the environment: the case for the precautionary principle. Environ Health Perspect 106 9 (1998) 523-529
3. Davis D.L., and Bradlow H.L. Can environmental estrogens cause breast cancer?. Sci Am 273 4 (1995) 167-172
4. Safe S., and Papineni S. The role of xenoestrogenic compounds in the development of breast cancer. Trends Pharmacol Sci 27 8 (2006) 447-454
5. Safe S.H. Xenoestrogens and breast cancer. N Engl J Med 337 18 (1997) 1303-1304
6. Safe S.H. Interactions between hormones and chemicals in breast cancer. Annu Rev Pharmacol Toxicol 38 (1998) 121-158
7. Sasco A.J. Epidemiology of breast cancer: an environmental disease?. Apmis 109 5 (2001) 321-332
8. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 2 (2005) 74-108
9. Forster C., Makela S., Warri A., Kietz S., Becker D., Hultenby K., et al. Involvement of estrogen receptor beta in terminal differentiation of mammary gland epithelium. Proc Natl Acad Sci U S A 99 24 (2002) 15578-15583
10. Russo J., Hu Y.F., Tahin Q., Mihaila D., Slater C., Lareef M.H., et al. Carcinogenicity of estrogens in human breast epithelial cells. Apmis 109 1 (2001) 39-52
11. Russo J., and Russo I.H. Genotoxicity of steroidal estrogens. Trends Endocrinol Metab 15 5 (2004) 211-214
12. Russo J., and Russo I.H. Development of the human breast. Maturitas 49 1 (2004) 2-15
13. Munoz-de-Toro M., Markey C.M., Wadia P.R., Luque E.H., Rubin B.S., Sonnenschein C., et al. Perinatal exposure to bisphenol-A alters peripubertal mammary gland development in mice. Endocrinology 146 9 (2005) 4138-4147
14. Bouskine A., Nebout M., Mograbi B., Brucker-Davis F., Roger C., and Fenichel P. Estrogens promote human testicular germ cell cancer through a membrane-mediated activation of extra-cellular regulated kinase and protein kinase-A. Endocrinology 149 (2008) 565-573
15. Thomas P., Pang Y., Filardo E.J., and Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146 2 (2005) 624-632
16. Service R.F. New role for estrogen in cancer?. Science 279 5357 (1998) 1631-1633
17. Cavalieri E.L., Stack D.E., Devanesan P.D., Todorovic R., Dwivedy I., Higginbotham S., et al. Molecular origin of cancer: catechol estrogen-3, 4-quinones as endogenous tumor initiators. Proc Natl Acad Sci U S A 94 20 (1997) 10937-10942
18. Thompson P.A., Shields P.G., Freudenheim J.L., Stone A., Vena J.E., Marshall J.R., et al. Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. Cancer Res 58 10 (1998) 2107-2110
19. Ezratti V. L'hypothèse des perturbateurs endocriniens : sensationnalisme ou science ?. Press Med 28 (1999) 758-763
20. Davis D.L., Bradlow H.L., Wolff M., Woodruff T., Hoel D.G., and Anton-Culver H. Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ Health Perspect 101 5 (1993) 372-377
21. Chang Y., Zhu X.Q., Zhu H.J., Zheng Y.F., and Huang X.S. Assessment of the estrogenicity of endosulfan and other chemicals with the in vitro proliferation of human breast cancer cell. Zhejiang Da Xue Xue Bao Yi Xue Ban 31 4 (2002) 281-283
22. Gray L.J. Chemical-induced alterations of sexual differentiation: a review of effects in humans and rodens (1992), Scientific publishing Princeton, Princeton pp. 230-303
23. Steinmetz R., Young P.C., Caperell-Grant A., Gize E.A., Madhukar B.V., Ben-Jonathan N., et al. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells. Cancer Res 56 23 (1996) 5403-5409
24. Jansen H.T., Cooke P.S., Porcelli J., Liu T.C., and Hansen L.G. Estrogenic and antiestrogenic actions of PCBs in the female rat: in vitro and in vivo studies. Reprod Toxicol 7 3 (1993) 237-248
25. Nesaretnam K., Corcoran D., Dils R.R., and Darbre P. P., 3,4,3′, 4′-Tetrachlorobiphenyl acts as an estrogen in vitro and in vivo. Mol Endocrinol 10 8 (1996) 923-936
26. Jobling S., Reynolds T., White R., Parker M.G., and Sumpter J.P. A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estrogenic. Environ Health Perspect 103 6 (1995) 582-587
27. Krishnan A.V., Stathis P., Permuth S.F., Tokes L., and Feldman D. Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology 132 6 (1993) 2279-2286
28. Manz A., Berger J., Dwyer J.H., Flesch-Janys D., Nagel S., and Waltsgott H. Cancer mortality among workers in chemical plant contaminated with dioxin. Lancet 338 8773 (1991) 959-964
29. Kuratsune M., Ikeda M., Nakamura Y., and Hirohata T. A cohort study on mortality of "yusho" patients: a preliminary report. Princess Takamatsu Symp 18 (1987) 61-66
30. Demers A., Ayotte P., Brisson J., Dodin S., Robert J., and Dewailly E. Risk and aggressiveness of breast cancer in relation to plasma organochlorine concentra tions. Cancer Epidemiol Biomarkers Prev 9 2 (2000) 161-166
31. Liljegren G., Hardell L., Lindstrom G., Dahl P., and Magnuson A. Case-control study on breast cancer and adipose tissue concentrations of congener specific polychlorinated biphenyls, DDE and hexachlorobenzene. Eur J Cancer Prev 7 2 (1998) 135-140
32. Romieu I., Hernandez-Avila M., Lazcano-Ponce E., Weber J.P., and Dewailly E. Breast cancer, lactation history, and serum organochlorines. Am J Epidemiol 152 4 (2000) 363-370
33. Demers A., Ayotte P., Brisson J., Dodin S., Robert J., and Dewailly E. Risk and aggressiveness of breast cancer in relation to plasma organochlorine concentrations. Cancer Epidemiol Biomarkers Prev 9 2 (2000) 161-166
34. Adami H.O., Lipworth L., Titus-Ernstoff L., Hsieh C.C., Hanberg A., Ahlborg U., et al. Organochlorine compounds and estrogen-related cancers in women. Cancer Causes Control 6 6 (1995) 551-566
35. Colborn T. Our stolen future (1996), Dutton, New York p. 307
36. Munoz-de-Toro M., Durando M., Beldomenico P.M., Beldomenico H.R., Kass L., Garcia S.R., et al. Estrogenic microenvironment generated by organochlorine residues in adipose mammary tissue modulates biomarker expression in ERalpha-positive breast carcinomas. Breast Cancer Res 8 4 (2006) R47
37. Calafat A.M., Kuklenyik Z., Reidy J.A., Caudill S.P., Ekong J., and Needham L.L. Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect 113 4 (2005) 391-395
38. Maffini M.V., Rubin B.S., Sonnenschein C., and Soto A.M. Endocrine disruptors and reproductive health: the case of bisphenol-A. Mol Cell Endocrinol 254-255 (2006) 179-186
39. Vandenberg L.N., Maffini M.V., Wadia P.R., Sonnenschein C., Rubin B.S., and Soto A.M. Exposure to environmentally relevant doses of the xenoestrogen bisphenol-A alters development of the fetal mouse mammary gland. Endocrinology 148 1 (2007) 116-127
40. Durando M., Kass L., Piva J., Sonnenschein C., Soto A.M., Luque E.H., et al. Prenatal bisphenol A exposure induces preneoplastic lesions in the mammary gland in Wistar rats. Environ Health Perspect 115 1 (2007) 80-86
41. Markey C.M., Luque E.H., Munoz De Toro M., Sonnenschein C., and Soto A.M. In utero exposure to bisphenol A alters the development and tissue organization of the mouse mammary gland. Biol Reprod 65 4 (2001) 1215-1223
42. Markey C.M., Wadia P.R., Rubin B.S., Sonnenschein C., and Soto A.M. Long-term effects of fetal exposure to low doses of the xenoestrogen bisphenol-A in the female mouse genital tract. Biol Reprod 72 6 (2005) 1344-1351
43. van Meeuwen J.A., Ter Burg W., Piersma A.H., van den Berg M., and Sanderson J.T. Mixture effects of estrogenic compounds on proliferation and pS2 expression of MCF-7 human breast cancer cells. Food Chem Toxicol 45 11 (2007) 2319-2330
44. Coumoul X., Diry M., Robillot C., and Barouki R. Differential regulation of cytochrome P450 1A1 and 1B1 by a combination of dioxin and pesticides in the breast tumor cell line MCF-7. Cancer Res 61 10 (2001) 3942-3948
45. Ibarluzea Jm J., Fernandez M.F., Santa-Marina L., Olea-Serrano M.F., Rivas A.M., Aurrekoetxea J.J., et al. Breast cancer risk and the combined effect of environmental estrogens. Cancer Causes Control 15 6 (2004) 591-600
46. Cohn B. Timing of DDT exposure and breast cancer before age 50; procedings of the International Society for Environnemental Epidemiology. Epidemiology 13 (2002) ps197
47. Cohn B.A., Wolff M.S., Cirillo P.M., and Sholtz R.I. DDT and breast cancer in young women: new data on the significance of age at exposure. Environ Health Perspect 115 10 (2007) 1406-1414
48. Land C.E., Tokunaga M., Koyama K., Soda M., Preston D.L., Nishimori I., et al. Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1990. Radiat Res 160 6 (2003) 707-717
49. Barker D.J., Winter P.D., Osmond C., Margetts B., and Simmonds S.J. Weight in infancy and death from ischaemic heart disease. Lancet 2 8663 (1989) 577-580
50. Fenichel P. Environnement, exposition fœtale et reproduction. Med Ther Med Reprod 9 (2007) p98
51. Palmer J.R., Hatch E.E., Rosenberg C.L., Hartge P., Kaufman R.H., Titus-Ernstoff L., et al. Risk of breast cancer in women exposed to diethylstilbestrol in utero: prelimiinary results (United States). Cancer Causes Control 13 8 (2002) 753-758
52. Maltoni C., Ciliberti A., Cotti G., Conti B., Belpoggi F., and Benzene. an experimental multipotential carcinogen: results of the long-term bioassays performed at the Bologna Institute of Oncology. Environ Health Perspect 82 (1989) 109-124
53. Kang K.S., Wilson M.R., Hayashi T., Chang C.C., and Trosko J.E. Inhibition of gap junctional intercellular communication in normal human breast epithelial cells after treatment with pesticides, PCBs, and PBBs, alone or in mixtures. Environ Health Perspect 104 2 (1996) 192-200
54. Helzlsouer K.J., Hayes J.D., Selmin O., Huang H.Y., Srickland P.T., Hoffman S., et al. Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. J Natl Cancer Inst 90 (1998) 512-518
55. Musgrave M.A., Aronson K.J., Narod S., Hanna W., Miller A.B., and McCready D.R. Breast cancer and organochlorines: a marker for susceptibility?. Surg Oncol 7 1-2 (1998) 1-4
56. Ho S.M., Tang W.Y., Belmonte de Frausto J., and Prins G.S. Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res 66 11 (2006) 5624-5632
57. Krieger N., Wolff M.S., Hiatt R.A., Rivera M., Vogelman J., and Orentreich N. Breast cancer and serum organochlorines: a prospective study among white, black, and Asian women. J Natl Cancer Inst 86 8 (1994) 589-599
58. Hunter D.J., Hankinson S.E., Laden F., Colditz G.A., Manson J.E., Willett W.C., et al. Plasma organochlorine levels and the risk of breast cancer. N Engl J Med 337 18 (1997) 1253-1258
59. van't Veer P., Lobbezoo I.E., Martin-Moreno J.M., Guallar E., Gomez-Aracena J., Kardinaal A.F., et al. DDT (dicophane) and postmenopausal breast cancer in Europe: case-control study. BMJ 315 7100 (1997) 81-85
60. Lopez-Carrillo L., Blair A., Lopez-Cervantes M., Cebrian M., Rueda C., Reyes R., et al. Dichlorodiphenyltrichloroethane serum levels and breast cancer risk: a case-control study from Mexico. Cancer Res 57 17 (1997) 3728-3732
61. Stellman S.D., Djordjevic M.V., Britton J.A., Muscat J.E., Citron M.L., Kemeny M., et al. Breast cancer risk in relation to adipose concentrations of organochlorine pesticides and polychlorinated biphenyls in Long Island, New York. Cancer Epidemiol Biomarkers Prev 9 11 (2000) 1241-1249
62. Wolff M.S., Zeleniuch-Jacquotte A., Dubin N., and Toniolo P. Risk of breast cancer and organochlorine exposure. Cancer Epidemiol Biomarkers Prev 9 3 (2000) 271-277
63. Dorgan J.F., Brock J.W., Rothman N., Needham L.L., Miller R., Stephenson Jr. H.E., et al. Serum organochlorine pesticides and PCB and breast cancer risk: results from a prospective analysis (USA). Cancer Causes Control 10 1 (1999) 1-11
64. Aronson K.J., Miller A.B., Woolcott C.G., Sterns E.E., McCready D.R., Lickley L.A., et al. Breast adipose tissue concentrations of polychlorinated biphenyls and other organochlorines and breast cancer risk. Cancer Epidemiol Biomarkers Prev 9 1 (2000) 55-63
65. Cassidy R.A., Natarajan S., and Vaughan G.M. The link between the insecticide heptachlor epoxide, estradiol, and breast cancer. Breast Cancer Res Treat 90 1 (2005) 55-64
66. Charlier C., Albert A., Herman P., Hamoir E., Gaspard U., Meurisse M., et al. Breast cancer and serum organochlorine residues. Occup Environ Med 60 5 (2003) 348-351
67. Falck Jr. F., Ricci Jr. A., Wolff M.S., Godbold J., and Deckers P. Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer. Arch Environ Health 47 2 (1992) 143-146
68. Henderson A.K., Rosen D., Miller G.L., Figgs L.W., Zahm S.H., Sieber S.M., et al. Breast cancer among women exposed to polybrominated biphenyls. Epidemiology 6 5 (1995) 544-546
69. Hoyer A.P., Grandjean P., Jorgensen T., Brock J.W., and Hartvig H.B. Organochlorine exposure and risk of breast cancer. Lancet 352 9143 (1998) 1816-1820
70. Hoyer A.P., Jorgensen T., Brock J.W., and Grandjean P. Organochlorine exposure and breast cancer survival. J Clin Epidemiol 53 3 (2000) 323-330
71. Mussalo-Rauhamaa H., Hasanen E., Pyysalo H., Antervo K., Kauppila R., and Pantzar P. Occurrence of beta-hexachlorocyclohexane in breast cancer patients. Cancer 66 10 (1990) 2124-2128
72. Woolcott C.G., Aronson K.J., Hanna W.M., SenGupta S.K., McCready D.R., Sterns E.E., et al. Organochlorines and breast cancer risk by receptor status, tumor size, and grade (Canada). Cancer Causes Control 12 5 (2001) 395-404
73. Wolff M.S., Toniolo P.G., Lee E.W., Rivera M., and Dubin N. Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst 85 8 (1993) 648-652